Stroke units, tissue plasminogen activator, aspirin and neuroprotection: which stroke intervention could provide the greatest community benefit?

A Gilligan; Amanda Thrift; Jonathan Sturm; Helen Dewey; Richard Macdonell; Geoffrey Donnan

doi:10.1159/000087705

Stroke units, tissue plasminogen activator, aspirin and neuroprotection: which stroke intervention could provide the greatest community benefit?

A Gilligan, Amanda Thrift, Jonathan Sturm, Helen Dewey, Richard Macdonell, Geoffrey Donnan

Medicine Monash Health

Research output: Contribution to journal › Article › Research › peer-review

79 Citations (Scopus)

Original language	English
Pages (from-to)	239 - 244
Number of pages	6
Journal	Cerebrovascular Diseases
Volume	20
Issue number	4
DOIs	https://doi.org/10.1159/000087705
Publication status	Published - 2005

Access to Document

10.1159/000087705

Cite this

@article{44abb24756ee4fd6a1b3bcc46d72c8c3,

title = "Stroke units, tissue plasminogen activator, aspirin and neuroprotection: which stroke intervention could provide the greatest community benefit?",

author = "A Gilligan and Amanda Thrift and Jonathan Sturm and Helen Dewey and Richard Macdonell and Geoffrey Donnan",

year = "2005",

doi = "10.1159/000087705",

language = "English",

volume = "20",

pages = "239 -- 244",

journal = "Cerebrovascular Diseases",

issn = "1015-9770",